These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 36300981)

  • 1. Audio Interview: Assessing the Effect of Vaccination and Prior SARS-CoV-2 Infection.
    Rubin EJ; Baden LR; Morrissey S
    N Engl J Med; 2022 Oct; 387(17):e50. PubMed ID: 36300981
    [No Abstract]   [Full Text] [Related]  

  • 2. Audio Interview: Antibody Responses to Natural Infection and Vaccination.
    Rubin EJ; Baden LR; Morrissey S
    N Engl J Med; 2021 Apr; 384(14):e65. PubMed ID: 33826826
    [No Abstract]   [Full Text] [Related]  

  • 3. Antibody responses after SARS-CoV-2 vaccination in patients with lymphoma.
    Lim SH; Campbell N; Johnson M; Joseph-Pietras D; Collins GP; O'Callaghan A; Fox CP; Ahearne M; Johnson PWM; Goldblatt D; Davies AJ
    Lancet Haematol; 2021 Aug; 8(8):e542-e544. PubMed ID: 34224667
    [No Abstract]   [Full Text] [Related]  

  • 4. Hybrid Immunity More Protective Than Prior SARS-CoV-2 Infection Alone.
    Larkin H
    JAMA; 2023 Feb; 329(7):531. PubMed ID: 36723971
    [No Abstract]   [Full Text] [Related]  

  • 5. [Vaccination immunology in SARS-CoV-2].
    Helweg-Larsen J; Benfield T
    Ugeskr Laeger; 2021 Mar; 183(11):. PubMed ID: 33734074
    [TBL] [Abstract][Full Text] [Related]  

  • 6. SARS-CoV-2 infection confers greater immunity than shots.
    Wadman M
    Science; 2021 Sep; 373(6559):1067-1068. PubMed ID: 34516858
    [No Abstract]   [Full Text] [Related]  

  • 7. Measuring cellular and humoral immunogenicity of a SARS-CoV-2 mRNA vaccine (BNT126b2) in patients on maintenance haemodialysis.
    Martin P; Clarke C
    EBioMedicine; 2021 Sep; 71():103567. PubMed ID: 34454401
    [No Abstract]   [Full Text] [Related]  

  • 8. Serological response in health care workers after a single dose of SARS-CoV-2 vaccine using six automated SARS-CoV-2 antibody assays.
    Cuykx M; Mortelé O; Jansens H; Schouwers S; Meskal A; Hoffbauer I; Peeters B
    Diagn Microbiol Infect Dis; 2021 Oct; 101(2):115486. PubMed ID: 34332306
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Possible Role for Anti-idiotype Antibodies in SARS-CoV-2 Infection and Vaccination.
    Murphy WJ; Longo DL
    N Engl J Med; 2022 Jan; 386(4):394-396. PubMed ID: 34818473
    [No Abstract]   [Full Text] [Related]  

  • 10. [Immune memory against SARS-CoV-2: Antibodies against the initial infection and memory B cells for the future ones].
    Reynaud CA; Weill JC; Chappert P; Mahévas M
    Med Sci (Paris); 2021; 37(8-9):722-725. PubMed ID: 34346865
    [No Abstract]   [Full Text] [Related]  

  • 11. Comparison of neutralizing antibody responses against SARS-CoV-2 in healthy volunteers who received the BNT162b2 mRNA or the AZD1222 vaccine: Should the second AZD1222 vaccine dose be given earlier?
    Terpos E; Trougakos IP; Karalis V; Ntanasis-Stathopoulos I; Sklirou AD; Bagratuni T; Papanagnou ED; Patseas D; Gumeni S; Malandrakis P; Korompoki E; Dimopoulos MA
    Am J Hematol; 2021 Sep; 96(9):E321-E324. PubMed ID: 34028867
    [No Abstract]   [Full Text] [Related]  

  • 12. Comparison of SARS-CoV-2 Antibody Response Following Vaccination With BNT162b2 and mRNA-1273.
    Steensels D; Pierlet N; Penders J; Mesotten D; Heylen L
    JAMA; 2021 Oct; 326(15):1533-1535. PubMed ID: 34459863
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Audio Interview: How Well Are Covid-19 Vaccines Working?
    Rubin EJ; Baden LR; Morrissey S
    N Engl J Med; 2021 Jul; 385(2):e15. PubMed ID: 34233102
    [No Abstract]   [Full Text] [Related]  

  • 14. Presence of SARS-CoV-2 antibodies in lactating women and their infants following BNT162b2 messenger RNA vaccine.
    Schwartz A; Nir O; Toussia-Cohen S; Leibovich L; Strauss T; Asraf K; Doolman R; Sharabi S; Cohen C; Levin EG; Lustig Y; Regev-Yochay G; Yinon Y
    Am J Obstet Gynecol; 2021 Nov; 225(5):577-579. PubMed ID: 34352250
    [No Abstract]   [Full Text] [Related]  

  • 15. Low titers of SARS-CoV-2 neutralizing antibodies after first vaccination dose in cancer patients receiving checkpoint inhibitors.
    Terpos E; Zagouri F; Liontos M; Sklirou AD; Koutsoukos K; Markellos C; Briasoulis A; Papanagnou ED; Trougakos IP; Dimopoulos MA
    J Hematol Oncol; 2021 May; 14(1):86. PubMed ID: 34059088
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Previous Infection Combined with Vaccination Produces Neutralizing Antibodies with Potency against SARS-CoV-2 Variants.
    Ibarrondo FJ; Hofmann C; Ali A; Ayoub P; Kohn DB; Yang OO
    mBio; 2021 Dec; 12(6):e0265621. PubMed ID: 34872349
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Audio Interview: How Much Protection Does Prior SARS-CoV-2 Infection Provide?
    Rubin EJ; Baden LR; Morrissey S
    N Engl J Med; 2021 Dec; 385(25):e100. PubMed ID: 34910868
    [No Abstract]   [Full Text] [Related]  

  • 18. Endemic SARS-CoV-2 will maintain post-pandemic immunity.
    Veldhoen M; Simas JP
    Nat Rev Immunol; 2021 Mar; 21(3):131-132. PubMed ID: 33402727
    [TBL] [Abstract][Full Text] [Related]  

  • 19. T cell immunity to SARS-CoV-2 following natural infection and vaccination.
    DiPiazza AT; Graham BS; Ruckwardt TJ
    Biochem Biophys Res Commun; 2021 Jan; 538():211-217. PubMed ID: 33190827
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Studying SARS-CoV-2 infectivity and therapeutic responses with complex organoids.
    Chen KG; Park K; Spence JR
    Nat Cell Biol; 2021 Aug; 23(8):822-833. PubMed ID: 34341531
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.